Clinical Trials Logo

Citation(s)

  •   Baker BM, Block BL, Rothchild AC, Walker BD
    Elite control of HIV infection: implications for vaccine design. Expert Opin Biol Ther. 2009 Jan;9(1):55-69. doi: 10.1517/14712590802571928 . Review.
  •   Browne EP, Littman DR
    Myd88 is required for an antibody response to retroviral infection. PLoS Pathog. 2009 Feb;5(2):e1000298. doi: 10.1371/journal.ppat.1000298. Epub 2009 Feb 13.
  •   Zwolinska K
    [Host genetic factors associated with susceptibility to HIV infection and progression of infection]. Postepy Hig Med Dosw (Online). 2009 Feb 24;63:73-91. Review. Polish.

Characterization of the Innate Immune Response to Candidate HIV Vaccines, an Ancillary Study to HVTN 205

Details for clinical trial NCT00908323